Powered by

Vascular Therapies Appoints John McDermott as Chief Executive Officer

Jan 09, 2019 - PR Newswire
Board and Executive Moves

PR Newswire

 Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease, today announced the appointment of John McDermott as the Company's Chief Executive Officer.

Bob Croce, Chairman of the Board of Directors of Vascular Therapies, Inc. commented, "We are very pleased to welcome John as our Chief Executive Officer.  John has nearly 30 years of experience in the vascular industry and has led the development and successful co...